3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Squamous Cell Carcinoma of Head and Neck
7
Rectal Neoplasms
7
Oropharyngeal Neoplasms
7
Head and Neck Neoplasms
6
Carcinoma, Non-Small-Cell Lung
5
Pancreatic Neoplasms
3
Lung Neoplasms
3
Hypopharyngeal Neoplasms
3
Glioblastoma
3
Esophageal Neoplasms
3
Uterine Cervical Neoplasms
2
Stomach Neoplasms
2
Radiation Injuries
2
Pathologic Complete Response
2
Nasopharyngeal Carcinoma
2
Mouth Neoplasms
2
Laryngeal Neoplasms
2
Vaginal Neoplasms
1
Uterine Cervical Dysplasia
1
Urinary Bladder Neoplasms
1
Tobacco Use Disorder
1
Thymoma
1
Smoking Cessation
1
Smoking
1
Small Cell Lung Carcinoma
1
Sinonasal undifferentiated carcinoma
1
Sinonasal Squamous Cell Carcinoma
1
Resectable Esophageal Cancer
1
Rectal Malignant Neoplasms
1
Postoperative Complications
1
Interventions
Granulocyte-Macrophage Colony-Stimulating Factor
1
Colony-Stimulating Factors
1
Chemoradiotherapy
1
Adjuvants, Immunologic
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Resectable Esophageal Cancer
×
Chemoradiotherapy
×
1 year
×
Clear all
NCT07385664
2026-02-04
FAIR
Zhejiang Cancer Hospital
Phase 2
Not yet recruiting
66 enrolled